.png?width=700&name=New-ATE-Logo2019%20(1).png)
The Path Toward Successful
Innovation in Gene Therapies
Please join us for this free, live Ask the Expert webcast.
Just fill out the form below to register.
Presenters:
Roland W. Herzog, PhD
Professor of Pediatrics, Riley Children’s Foundation Professor of Immunology, and Director of the Gene and Cell Therapy Program Indiana University School of Medicine
Professor of Pediatrics, Riley Children’s Foundation Professor of Immunology, and Director of the Gene and Cell Therapy Program Indiana University School of Medicine
Dr. Herzog is the Editor-in-Chief of the Molecular Therapy journal from the American Society of Gene and Cell Therapy as well as Professor of Pediatrics, Riley Children’s Foundation Professor of Immunology, and Director of the Gene and Cell Therapy Program, Indiana University School of Medicine. Dr. Herzog is a recipient of multiple awards from the American Society of Gene and Cell Therapy, the National Hemophilia Foundation, and the Bayer Hemophilia Program, in addition to others.
Nagendra Venkata Chemuturi, PhD
Scientific Director Research, Global DMPK
Takeda Pharmaceutical Company
Scientific Director Research, Global DMPK
Takeda Pharmaceutical Company
Nagendra Chemuturi received his bachelor’s degree in Pharmacy, with Distinction and Gold Medals, from Kakatiya University in India. He then worked as a pharmaceutical sales representative before pursuing his PhD at the University of Iowa. He was awarded the American Association of Pharmaceutical Scientists (AAPS) Graduate Symposium Award in 2005 for his dissertation work on the role of nasal drug transporters and metabolism in preferential nose-to-brain uptake of dopamine into the brain. He started his career in the US at Vertex Pharmaceuticals in Massachusetts in 2005. Since then, he has worked at Alcon-Novartis, Seattle Genetics, and Novartis Institutes for BioMedical Research. He is currently with Takeda Pharmaceuticals. His experience lies in the fields of oncology and ophthalmology, having served as DMPK lead on several small and large molecule projects. He is currently working on viral gene therapies including clinical aspects of viral gene therapies. He has given podium presentations at several scientific conferences, is active in AAPS and IQ consortium, co-leading the MABEL working group, and has coauthored several articles and book chapters.
